Lars Lidgren
Follow
Get notifications in MyBN when activity occurs.
Lars Lidgren
Professor Lars Lidgren has authored and co-authored over 250 original publications, and has more than 150 patents/applications.
Prof Lidgren was spokesman for Biomaterials in the Nordic Orthopaedic Society, chair of the Swedish National Knee Register, director of the National Board of Health and Welfare, Musculoskeletal Competence Centre, and member of several editorial boards.
Prof Lidgren initiated and has led the UN ratified Bone and Joint Decade and founded Scandimed, a global leading company in bone cements and delivery which was subsequently acquired by Biomet. He is the inventor, founder and board member of Bone Support, an emerging leader in bone therapeutics.
Prof Lidgren was spokesman for Biomaterials in the Nordic Orthopaedic Society, chair of the Swedish National Knee Register, director of the National Board of Health and Welfare, Musculoskeletal Competence Centre, and member of several editorial boards.
Prof Lidgren initiated and has led the UN ratified Bone and Joint Decade and founded Scandimed, a global leading company in bone cements and delivery which was subsequently acquired by Biomet. He is the inventor, founder and board member of Bone Support, an emerging leader in bone therapeutics.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 91st | Botanix Pharmaceuticals | 100% | 43% |
| 516th | Orthocell | 10% | 27% |
| 536th | Proteomics International Laboratories | 8% | 26% |
| 1095th | Adisyn | -25% | |
| 1612th | Nuheara | -60% | -44% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 124th |  | Orthocell | $4.3m |
| 131st |  | Nuheara | $3.8m |
| 132nd | | Botanix Pharmaceuticals | $3.8m |
| 136th | | Proteomics International Laboratories | $3.2m |
| 137th | | Adisyn | $2.9m |
202 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in Board Moves September 22, 2023 | 22 Sep 2023 |
| REMUNERATION UPDATE: Non-Executive Director, Orthocell | 02 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Orthocell | 24 Aug 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Orthocell | 30 Jun 2020 |
News Articles
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Non-Executive Director | | 2007 - 2023 | 124 |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| Orthocell | 20 Nov 2022 | Other | 500,000 | OtherOptions expired | ||
| Orthocell | 07 Nov 2022 | Bought | 45,000 | $0.43 | $19,350 | Off-market trade |
| Orthocell | 07 Nov 2022 | Bought | 45,000 | $0.43 | $19,350 | Off-market trade |
| Orthocell | 22 Jan 2021 | Other | 300,000 | $0.57 | $172,260 | Exercise of options |
| Orthocell | 22 Jan 2021 | Issued | 93,625 | $0.57 | $53,759 | Exercise of options |
Powered by Morningstar ®
